Thực trạng sử dụng thuốc điều trị bệnh basedow trên bệnh nhân nội trú

0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Đăng Minh Trí Bùi, Đức Thái Hoàng, Thế Hải Nguyễn

Ngôn ngữ: Vie

Ký hiệu phân loại: 615 Pharmacology and therapeutics

Thông tin xuất bản: Y học cộng đồng 2021

Mô tả vật lý:

Bộ sưu tập: Metadata

ID: 397036

Thêm vào giỏ Liên kết toàn văn

Đánh giá thực trạng sử dụng thuốc điều trị bệnh Basedow trên bệnh nhân nội trú tại Bệnh viện Đa khoa thành phố Cần Thơ.Đối tượng và phương pháp:Nghiên cứu hồi cứu trên 70 bệnh án của bệnh nhân Basedow điều trị nội trú lần đầu được lưu trữ tại phòng Chỉ đạo tuyến của Bệnh viện Đa khoa thành phố Cần Thơ từ tháng 01/07/2020 - 30/09/2020.Kết quả:Tất cả bệnh nhân đều sử dụng thuốc kháng giáp tổng hợp (KGTH). Thuốc nhóm chẹn β giao cảm chiếm 91,43%. Nhóm các thuốc hỗ trợ điều trị chiếm 97,14%, trong đó thuốc bổ gan chiếm tỷ lệ lớn nhất là 97,14%. Đa số các bệnh nhân sử dụng phác đồ phối hợp 3 nhóm thuốc để điều trị chiếm tỷ lệ 77,14%. Phác đồ đơn trị liệu được sử dụng ít nhất với tỷ lệ 2,86%. Chỉ có 2,86% bệnh nhân sử dụng 1 loại thuốc nhóm KGTH để điều trị. Tỷ lệ phải đổi thuốc để điều trị chiếm 10,0%.Kết luận:Thuốc KGTH là lựa chọn bắt buộc cho bệnh nhân basedow điều trị nội trú. Chủ yếu bệnh nhân cần sử dụng phác đồ phối hợp 3 thuốc để điều trị. Tỷ lệ phải đổi phác đồ điều trị chiếm tỷ lệ thấp., Tóm tắt tiếng anh, To assess the current situation of using drugs for treating Basedow disease on inpatients at Can Tho City General Hospital. Objects and methods: Retrospective study of over 70 medical records of Basedow patients for the first inpatient treatment, stored at the Steering Room of Can Tho City General Hospital from July, 1 st , 2020 - September, 30 th, 2020. Results: All patients used synthetic antithyroid drugs. β blockers accounted for 91.43%. The group of drugs supporting treatment accountsed for 97.14%, of which liver tonic accounted for the largest proportion of 97.14%. The majority of patients using a combination regimen of 3 drug groups for treatment accounted for 77.14%. Monotherapy regimen used at least 2.86%. Only 2.86% of patients used 1 drug of antithyroid group for treatment. The percentage of people had to change drugs for treatment was 10.0%. Conclusion: Synthetic antithyroid drug was a mandatory option for patients based on inpatient treatment. Mostly, patients needed to use a 3-drug combination regimen for treatment. The proportion of people had to change the treatment regimen accounted for a low rate.

1. Đọc trực tuyến

1. Đọc trực tuyến

Tạo bộ sưu tập với mã QR